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Extensive evidence indicates that glucocorticoid hormones act in a variety of brain
regions to enhance the consolidation of memory of emotionally motivated training
experiences. We previously reported that corticosterone, the major glucocorticoid in the
rat, administered into the dorsal striatum immediately after inhibitory avoidance training
dose-dependently enhances memory consolidation of this training. There is also abundant
evidence that the intrinsic cholinergic system of the dorsal striatum is importantly involved
in memory consolidation of inhibitory avoidance training. However, it is presently unknown
whether these two neuromodulatory systems interact within the dorsal striatum in the
formation of long-term memory. To address this issue, we first investigated in male
Wistar rats whether the muscarinic receptor agonist oxotremorine administered into the
dorsal striatum immediately after inhibitory avoidance training enhances 48h retention
of the training. Subsequently, we examined whether an attenuation of glucocorticoid
signaling by either a systemic administration of the corticosterone-synthesis inhibitor
metyrapone or an intra-striatal infusion of the glucocorticoid receptor (GR) antagonist
RU 38486 would block the memory enhancement induced by oxotremorine. Our findings
indicate that oxotremorine dose-dependently enhanced 48h retention latencies, but that
the administration of either metyrapone or RU 38486 prevented the memory-enhancing
effect of oxotremorine. In the last experiment, corticosterone was infused into the dorsal
striatum together with the muscarinic receptor antagonist scopolamine immediately after
inhibitory avoidance training. Scopolamine blocked the enhancing effect of corticosterone
on 48 h retention performance. These findings indicate that there are mutual interactions
between glucocorticoids and the striatal cholinergic system in enhancing the consolidation
of memory of inhibitory avoidance training.
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INTRODUCTION
It is well established that glucocorticoid hormones (corticos-
terone in rodents, cortisol in humans), released from the adrenal
cortex during stressful episodes, act in a neurocircuitry of inter-
connected brain regions to enhance the consolidation of memory
of emotionally arousing training experiences (de Kloet et al.,
1999; Roozendaal, 2002; McGaugh, 2004; Miranda et al., 2008;
Roozendaal et al., 2009; Joëls et al., 2011; Schwabe et al., 2012).
For example, corticosterone or a specific glucocorticoid receptor
(GR) agonist administered into either the basolateral complex of
the amygdala (BLA) or hippocampus is known to enhance mem-
ory consolidation of inhibitory avoidance training or of other
training with a strong contextual component (Roozendaal and
McGaugh, 1997a,b). Recently, we reported that the dorsal stria-
tum is another target structure for glucocorticoids in modulating
memory consolidation of inhibitory avoidance training (Medina
et al., 2007). However, as glucocorticoid infusions into the dorsal
striatum failed to enhance memory of either the footshock or
contextual aspects of inhibitory avoidance training (Medina et al.,
2007), these findings suggest that corticosterone might act within
the dorsal striatum to specifically enhance the consolidation of
memory of procedural aspects of inhibitory avoidance training,
consistent with the evidence that the dorsal striatum is crucially
involved in memory formation of procedural or non-declarative
training (Packard and White, 1991; McDonald and White, 1993;
Packard et al., 1994; Packard and Knowlton, 2002; Prado-Alcalá
et al., 2003; White, 2009).
One of the neurotransmitter systems of the dorsal striatum
that has received most attention is its intrinsic cholinergic sys-
tem. On the one hand, it has been shown that striatal cholinergic
interneurons are involved in motor control, as seen in humans
where dysfunction of this complex system leads to movement
disorders such as Huntington’s and Parkinson’s disease (Sandberg
et al., 1984; Galarraga et al., 1999; Pisani et al., 2001;Wilson, 2004;
Graybiel, 2008). On the other hand, muscarinic receptor antago-
nists administered into the dorsal striatum are known to induce
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retrograde amnesia of inhibitory avoidance training (Haycock
et al., 1973; Prado-Alcalá et al., 1980) in a time- and dose-
dependent fashion (Prado-Alcalá et al., 1984b, 1985; Giordano
and Prado-Alcalá, 1986), whereas the intra-striatal administra-
tion of muscarinic receptor agonists improves retention of this
training (Solana-Figueroa and Prado-Alcalá, 1990). Additional
support for the view that the striatal cholinergic system modu-
lates memory consolidation came from experiments indicating
that local activation or blockade of the cholinergic system either
enhances or impairs memory of active avoidance, lever pressing,
and autoshaping (Neill and Grossman, 1970; Prado-Alcalá et al.,
1984a; Bermúdez-Rattoni et al., 1986).
Several findings indicate that stress exposure influences activ-
ity of the cholinergic system in the brain (Mark et al., 1996; Ortega
et al., 1996; Gold, 2003) as well as that the stress associated with
certain training procedures can alter cholinergic activity (Tajima
et al., 1996; Orsini et al., 2001; Helm et al., 2004). However,
much less is known of whether such stress effects on choliner-
gic activity are mediated by glucocorticoid actions. Given that
both glucocorticoids and the cholinergic system play an impor-
tant role within the dorsal striatum in memory consolidation,
the present study investigated whether glucocorticoids and the
striatal cholinergic system interact in modulating memory con-
solidation of inhibitory avoidance training. To address this issue,
we first investigated whether the muscarinic receptor agonist
oxotremorine administered into the dorsal striatum immediately
after inhibitory avoidance training enhances the consolidation of
memory of the training experience. Subsequently, we examined
whether either systemic administration of the corticosterone-
synthesis inhibitor metyrapone, suppressing the endogenous cor-
ticosterone response, or an infusion of the GR antagonist RU
38486 directly into the dorsal striatum would block the enhancing
effect of oxotremorine on inhibitory avoidance memory. In the
last experiment, we used a complementary approach and investi-
gated whether a blockade of muscarinic receptors in the dorsal
striatum after inhibitory avoidance training would prevent the
memory enhancement induced by corticosterone.
MATERIALS ANDMETHODS
ANIMALS
Adult male Wistar rats (250–350 g at the time of surgery),
obtained from the breeding colony of the Instituto de
Neurobiología, Universidad Nacional Autónoma de México, were
housed individually in acrylic cages with food and tap water avail-
able ad libitum. They were maintained on a 12/12 h light-dark
cycle (lights on at 7:00 h) and a constant room temperature of
21◦C. The rats were randomly assigned to the different experi-
mental groups, with initial sample sizes ranging from 10 to 12
rats per group. All experimental procedures were approved by
the Animal Ethics Committee of the Instituto de Neurobiología,
Universidad Nacional Autónoma de México, and were in com-
pliance with the “Principles of Laboratory Animal Care” of the
National Institutes of Health.
SURGERY
Animals, adapted to the colony room for at least one week,
were anesthetized with sodium pentobarbital (50mg/kg of body
weight, ip) and given atropine sulfate (0.4mg/kg, ip) to main-
tain respiration. The skull was positioned in a stereotaxic frame
(Stoelting, Co. IL) and two stainless-steel guide cannulae (11mm
long, 23 gauge) were implanted into the anterior division of
the dorsal striatum (coordinates: anteroposterior, 0.0mm from
Bregma; mediolateral, ±3.2mm from midline; dorsoventral,
4.2mm below skull surface, incisor bar −3.3mm from interau-
ral line) according to the atlas of Paxinos and Watson (2005).
The cannulae were affixed to the skull with two anchoring screws
and dental cement. Stylets (11mm long 00-insect dissection pins)
were inserted into each cannula to maintain patency and were
removed only for the infusion of drugs. After surgery, the rats
received a subcutaneous 1ml injection of saline to prevent dehy-
dration and were retained within an incubator until recovered
from anesthesia and were then returned to their home cages. The
rats were allowed to recover for a minimum of seven days before
initiation of training and were handled three times for 3min each
during this period to accustom them to the infusion procedures.
INHIBITORY AVOIDANCE APPARATUS AND PROCEDURES
The rats were trained and tested in an inhibitory avoidance appa-
ratus consisting of a trough-shaped alley (20 cm wide at the top
and 8 cm wide at the bottom) with two distinct compartments
of the same size (30 × 30 × 30 cm), separated by a sliding door.
The starting compartment had walls and lid made of red-colored
acrylic with a floor of stainless steel bars (6mm in diameter, sep-
arated by 9mm) and was illuminated by a 10-W light bulb. The
shock compartment was made of two electrifiable stainless steel
plates and was not illuminated with its end walls and lid con-
structed of red-colored acrylic. In the middle of the floor, a 1.5 cm
slot separated the two stainless steel plates that made up the
walls and floor. The apparatus was located inside a dark, sound-
attenuated room provided with background masking noise (San
Diego Instruments).
For training, the rat was placed into the starting compartment
of the apparatus and 10 s later the sliding door was opened and
the latency to enter the dark compartment was recorded. After the
animal stepped into the shock compartment with all four paws,
the door was closed and a single, inescapable footshock (0.60mA,
1 s) was delivered using a precision-regulated animal shock gen-
erator (Coulbourn Instruments, USA). Automated equipment
controlled the duration of the footshock and measured the rat’s
latency to cross from one compartment to the other. The rat was
removed from the shock compartment 10 s after termination of
the footshock and, after drug treatment, returned to the home
cage. On the 48 h retention test, as on the training session, the
latency to re-enter the shock compartment with all four paws
(maximum latency of 600 s) was recorded and used as a measure
of retention. Longer latencies were interpreted as indicating better
retention. Shock was not administered on the retention test trial.
DRUG AND INFUSION PROCEDURES
The muscarinic receptor agonist oxotremorine (0.15, 0.30, 0.45,
0.60, or 1.0μg in 1μl, Sigma-Aldrich) was dissolved in sodium
phosphate buffer, pH 7.4, and infused into the dorsal striatum
immediately after inhibitory avoidance training. Bilateral infu-
sions of drug, or an equivalent volume of vehicle, were made using
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30-gauge injection needles connected to 10μl Hamilton microsy-
ringes by polyethylene (PE-20) tubing, driven by an automated
microinfusion pump (model 220i, WPI). The injection needles
protruded 2mm beyond the tip of the cannula and an injection
volume of 1μl per hemisphere was delivered over 1min. The
injection needles were retained within the cannulae for an addi-
tional minute following drug infusion to maximize diffusion and
prevent backflow of drug into the cannulae.
For adrenocortical suppression, the 11-β-hydroxylase
inhibitor metyrapone (2-methyl-1,2-di-3-pyridyl-1-propanone;
50mg/kg; Sigma-Aldrich) was injected subcutaneously in a
volume of 2ml/kg 90min before training. Metyrapone was first
dissolved in 100% polyethylene glycol and subsequently diluted
with 0.9% saline to reach the appropriate concentration. The
final concentration of polyethylene glycol was 40%. The vehicle
control contained the same polyethylene glycol concentration.
The dose of metyrapone was selected on the basis of previous
findings indicating that it effectively blocks stress-induced
increases in circulating levels of corticosterone without affecting
basal levels (Roozendaal et al., 1996). In this study we did not
measure corticosterone levels because there is evidence showing
that the dose of metyrapone that we used (50mg/kg) induced
a significant reduction of peripheral corticosterone levels and
produces memory impairment in different tasks such as passive
avoidance in chicks (Loscertales et al., 1997), conditioned taste
aversion (Miranda et al., 2008), spatial memory (Akirav et al.,
2004), and blocks the memory enhancing effects of amphetamine
or ephinephrine (Roozendaal et al., 1996) as well as the memory
facilitation by stressful conditions during learning (Conboy and
Sandi, 2010).
The GR antagonist RU 38486 (17β-hydroxy-11β-(4-
dimethylaminophenyl)-17α-(1-propynyl)-estra-4,9-dien-3-one;
10 ng in 1μl; Sigma-Aldrich) was microinjected into the dorsal
striatum 15min before training. RU 38486 was first dissolved
in 100% ethanol and subsequently diluted in saline. The final
ethanol concentration was 2%. The dose of RU 38486 was
selected on the basis of previous findings indicating that, when
administered into the dorsal striatum, it blocksmemory enhance-
ment of inhibitory avoidance training induced by concurrently
administered corticosterone (Medina et al., 2007).
For the last experiment, corticosterone (10 or 30 ng in
1μl; Sigma-Aldrich) was administered into the dorsal striatum
together with the muscarinic receptor antagonist scopolamine
(30μg; Sigma-Aldrich) immediately after inhibitory avoidance
training. Corticosterone and scopolamine were dissolved in a
vehicle containing 2% ethanol in phosphate buffer, pH 7.4. The
dose of corticosterone was selected on the basis of prior experi-
ments (Medina et al., 2007).
HISTOLOGY
After completion of behavioral testing, the rats were deeply
anesthetized with sodium pentobarbital and perfused transcar-
dially with isotonic saline followed by 4% formaldehyde. After
decapitation, the brains were removed and immersed in a 4%
formaldehyde solution for at least five days. Sections of 50μm
were cut on a cryostat and stained with cresyl-violet. The sec-
tions were examined under a light microscope, and the location of
injection needle tips within the dorsal striatum was determined.
Histological analysis revealed that the injection needle tips of
seven rats were not located within the boundaries of the targeted
area. The data of these animals were not included in the statisti-
cal analyses. Figure 1 shows the location of the injection needle
tips within the dorsal striatum of rats included in the statistical
analyses.
STATISTICS
Data are presented as median + interquartile ranges. Inhibitory
avoidance training and retention latencies were analyzed with
independent Kruskal–Wallis analyses of variance. When appro-
priate, Mann–Whitney U-tests were used to make comparisons
between any two groups. A probability level of <0.05 was
accepted as statistical significance. The number of rats per group
is indicated in the figure legends.
RESULTS
IMMEDIATE POST-TRAINING INFUSIONS OF OXOTREMORINE
INTO THE DORSAL STRIATUM DOSE-DEPENDENTLY ENHANCE
INHIBITORY AVOIDANCE MEMORY
The first experiment investigated whether bilateral infusions of
the muscarinic receptor agonist oxotremorine (0.15, 0.3, 0.45, 0.6
FIGURE 1 | Diagrams and photomicrograph illustrating the placement of
injection needle tips within the dorsal striatum of rats trained on the
inhibitory avoidance task. Large arrows point to the tracks left by the
cannula tips and small arrows point to those left by the injection needle tips.
Anterior-posterior coordinates are shown in mm from Bregma. Redrawn from
Paxinos and Watson (2005).
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or 1.0μg in 1μl) given immediately after inhibitory avoidance
training enhance performance on a 48 h retention test. Entrance
latencies during the training trial, before footshock or drug treat-
ment, did not differ among groups [H(5) = 5.15, P = 0.39; data
not shown]. As is shown in Figure 2, Kruskal–Wallis test for
48 h retention latencies revealed a significant group effect [H(5) =
18.24, P < 0.005]. Oxotremorine in a dose of 0.3μg produced
FIGURE 2 | Median latencies and interquartile ranges, in seconds on
the 48h inhibitory avoidance retention test of rats given immediate
post-training infusions of either vehicle (Veh) or the muscarinic
receptor agonist oxotremorine (0.15, 0.3, 0.45, 0.6, and 1.0μg) into the
dorsal striatum. The group that received the 0.3μg dose of oxotremorine
showed longer retention latencies. ∗P < 0.05 as compared to all other
groups (N = 10 rats/group).
significantly longer retention latencies than those of rats treated
with vehicle (P < 0.05). Lower or higher doses of oxotremorine
did not alter retention performance.
OXOTREMORINE-INDUCED MEMORY ENHANCEMENT DEPENDS
ON CONCURRENT GLUCOCORTICOID ACTIVATION
In this experiment we investigated whether an attenuation of
glucocorticoid signaling alters the memory-enhancing effects of
post-training muscarinic cholinergic activation within the dorsal
striatum. In the first part, rats were injected subcutaneously with
the corticosterone-synthesis inhibitor metyrapone (50mg/kg) or
vehicle 90min before inhibitory avoidance training, followed by
a bilateral intra-striatal infusion of oxotremorine (0.3 or 1.0μg)
immediately after the training trial. Entrance latencies during
training did not differ among groups [H(5) = 6.45 P = 0.26].
However, there were significant group differences in 48 h reten-
tion latencies [H(5) = 20.48, P = 0.001]. Consistent with the
findings of the first experiment, Mann–Whitney U-tests indi-
cated that rats treated with the 0.3μg dose of oxotremorine
had longer retention latencies than rats administered vehicle
or the higher dose of oxotremorine (P’s ranging from 0.05 to
0.005). Metyrapone treatment blocked the retention enhance-
ment induced by intra-striatal oxotremorine administration and
retention latencies of the metyrapone-oxotremorine (0.3μg)
group were significantly shorter than those of the vehicle-
oxotremorine (0.3μg) group (P < 0.002) (Figure 3A).
In the second part of the experiment, the GR antagonist RU
38486 (10 ng) was administered bilaterally into the dorsal stria-
tum 15min before training, followed by oxotremorine (0.3 or
1.0μg) immediately after the training. Entrance latencies dur-
ing the training trial did not differ among groups [H(5) = 7.61
P = 0.17]. During 48 h retention testing, significant group dif-
ferences were found [H(5) = 17.49, P < 0.005]. Rats treated with
FIGURE 3 | Median latencies and interquartile ranges, in seconds on the
48 h inhibitory avoidance retention test. (A) Post-training infusion of the
muscarinic receptor agonist oxotremorine (0.3μg) into the dorsal striatum
enhanced 48 h retention performance and a pre-training systemic
administration of the 11β-hydroxylase inhibitor metyrapone (50mg/kg)
blocked this retention enhancement. (B) The glucocorticoid receptor (GR)
antagonist RU 38486 (10 ng) administered into the dorsal striatum 15min
before inhibitory avoidance training also blocked the memory-enhancing
effect of oxotremorine (0.3μg) given immediately posttraining into the dorsal
striatum. ∗P < 0.05 as compared to the vehicle group (N = 10 rats/group).
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the lower dose of oxotremorine (0.3μg) had significantly longer
retention latencies than rats treated with either vehicle or the
higher dose of oxotremorine (P’s < 0.002 and 0.05, respectively).
In rats also administered RU 38486, the memory-enhancing effect
of oxotremorine was abolished and retention latencies of the
RU 38486-oxotremorine (0.3μg) group were significantly shorter
than those of the vehicle-oxotremorine (0.3μg) group (P < 0.05)
(Figure 3B).
CORTICOSTERONE-INDUCED MEMORY ENHANCEMENT DEPENDS
ON CHOLINERGIC ACTIVITY WITHIN THE DORSAL STRIATUM
To explore further the nature of the interaction between glu-
cocorticoids and the cholinergic system in memory consolida-
tion, corticosterone (10 or 30 ng) was administered bilaterally
into the dorsal striatum either alone or together with the mus-
carinic receptor antagonist scopolamine (30μg) immediately
after inhibitory avoidance training. Entrance latencies during the
training trial, before footshock or drug treatment, did not differ
among groups [H(5) = 5.15 P = 0.40]. As is shown in Figure 4,
Kruskal–Wallis analysis revealed significant differences in 48 h
retention latencies [H(5) = 11.28, P < 0.05]. The 10 ng dose of
corticosterone, but not the 30 ng dose, enhanced retention laten-
cies (P < 0.05). However, scopolamine treatment blocked the
memory-enhancing effect of corticosterone. Retention latencies
of rats given corticosterone (10 ng) together with scopolamine
were significantly shorter than those of rats given that dose of
corticosterone alone (P < 0.05).
DISCUSSION
The present findings indicate that glucocorticoids and the
cholinergic system of the dorsal striatum interact in enhancing
the consolidation of memory of inhibitory avoidance training.
Microinfusion of the muscarinic receptor agonist oxotremorine
into the dorsal striatum immediately after inhibitory avoidance
FIGURE 4 | Median latencies and interquartile ranges, in seconds on
the 48 h inhibitory avoidance retention test. The muscarinic receptor
antagonist scopolamine (30μg) administered into the dorsal striatum
immediately after inhibitory avoidance training blocked the
memory-enhancing effect of concurrently administered corticosterone
∗P < 0.05 as compared to the vehicle group (N = 8–11 rats/group).
training dose-dependently enhanced 48 h retention performance.
However, and importantly, an attenuation of glucocorticoid sig-
naling with either a systemic administration of the corticosterone-
synthesis inhibitormetyrapone or an intra-striatal administration
of the GR antagonist RU 38486 blocked the memory-enhancing
effect of oxotremorine. Further, we found that corticosterone
enhanced memory when infused into the dorsal striatum after
inhibitory avoidance training and that this corticosterone effect
was blocked in rats concurrently administered the muscarinic
receptor antagonist scopolamine.
The current finding that oxotremorine administered into the
dorsal striatum after inhibitory avoidance training enhanced
48 h retention performance is consistent with extensive evidence
from other studies indicating that post-training activation of
muscarinic receptors in this brain region enhances retention of
inhibitory avoidance training (Solana-Figueroa and Prado-Alcalá,
1990; Ortega et al., 1996; Packard et al., 1996) or of training on
several other learning tasks (Brimblecombe, 1964; Baratti et al.,
1979), whereas a post-training blockade of muscarinic recep-
tors impairs retention of inhibitory avoidance and other training
(Prado-Alcalá et al., 1984b; Giordano and Prado-Alcalá, 1986).
Similarly, our finding that post-training infusions of corticos-
terone into the dorsal striatum enhance retention of inhibitory
avoidance training is consistent with other recent findings from
our laboratory (Medina et al., 2007). As these memory-enhancing
drugs were administered after the training trial, non-specific drug
influences on the acquisition (i.e., footshock sensitivity, locomo-
tion, attention, arousal, etc.) are excluded. Also, because these
drugs are effective at enhancing long-term retention only when
given within several hours after the training experience (Flood
et al., 1978; Giordano and Prado-Alcalá, 1986; Sandi and Rose,
1994), the present findings strongly suggest that these drug effects
on retention performance are due selectively to influences on the
consolidation of long-term memory.
The aim of the present experiments was to investigate whether
the glucocorticoid and cholinergic systems of the dorsal stria-
tum interact in modulating memory consolidation of inhibitory
avoidance training. The interest of this question stems from
previous work indicating that stressful stimulation, either exoge-
nously or induced by the training procedure, can alter cholinergic
activity in the brain. Stressful stimuli are known to promote
the release of acetylcholine in the hippocampus (Mark et al.,
1996), which might directly contribute to the enhancing effects
of stress on synaptic plasticity and memory (Shinoe et al.,
2005). In addition to such immediate effects of stress-induced
acetylcholine release on synaptic plasticity, stressful experiences
might also regulate synaptic plasticity in a slower fashion by
increasing, for example, the genetic expression of cholinergic
nicotinic (Takita and Muramatsu, 1995) and muscarinic recep-
tors (Takayama et al., 1987; Mizukawa et al., 1989; Gonzalez
and Pazos, 1992; Kaufer et al., 1998; Brand et al., 2008). Our
findings indicating that a blockade of glucocorticoid signal-
ing prevented memory enhancement induced by oxotremorine
and, conversely, that a blockade of muscarinic receptors pre-
vented memory enhancement induced by corticosterone, sug-
gest that glucocorticoids might be involved in mediating at
least some of these stress effects on the cholinergic system.
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There is some evidence in other brain regions indicating inter-
actions between glucocorticoids and the cholinergic system. An
in vivo microdialysis study reported that complete removal of
glucocorticoids by adrenalectomy enhanced hippocampal levels
of acetylcholine in response to potassium chloride stimulation
(Mizoguchi et al., 2008). Another study investigated the interac-
tion between glucocorticoids and the cholinergic system within
the BLA in enhancing memory consolidation of inhibitory avoid-
ance training (Power et al., 2000). Consistent with the current
findings, blockade of muscarinic cholinergic activity within the
BLA with atropine prevented the memory-enhancing effect of a
concurrently administered GR agonist. In view of the evidence
that glucocorticoids enhance memory consolidation by facili-
tating arousal-induced noradrenergic activation within the BLA
(Quirarte et al., 1997; Roozendaal, 2002; Roozendaal et al., 2006),
these findings were interpreted in support of the view that nora-
drenergic activation requires downstream cholinergic signaling
within the BLA in enhancing memory consolidation (Introini-
Collison and McGaugh, 1988; Decker et al., 1990). Although
very little is known concerning a possible involvement of the
noradrenergic system within the dorsal striatum in memory con-
solidation, findings from our laboratory indicate that noradren-
ergic activity within the dorsal striatum is essential for mediating
glucocorticoid effects memory consolidation (Espinoza-González
et al., 2007). Thus, such findings suggest that glucocorticoids
migh interact with the cholinergic system indirectly via an acti-
vation of the noradrenergic system. However, the other findings
of the current study indicating that a blockade of glucocorticoid
signaling with either metyrapone or GR antagonist also prevented
the memory-enhancing effect of the muscarinic receptor agonist
oxotremorine cannot be readily explained by such a mechanism:
previous findings indicated that a blockade of β-adrenoceptor
activity within the BLA does not block the memory-enhancing
effect of a muscarinic receptor agonist (Introini-Collison et al.,
1996). Thus, these findings indicating that cholinergic effects on
memory consolidation require concurrent glucocorticoid signal-
ing suggest that glucocorticoids might also act within the dorsal
striatum at a level that is downstream of the cholinergic system.
As glucocorticoids and muscarinic receptor agonists are
known to act in many different brain regions, including the
BLA, hippocampus, and prefrontal cortex, in enhancing memory
consolidation of inhibitory avoidance training (Roozendaal and
McGaugh, 1997b; Roozendaal et al., 1999; Barsegyan et al., 2010),
what is so interesting about their effects in dorsal striatum? In
inhibitory avoidance, rats learn that they receive footshock in a
particular place. Previously, we developed a modified inhibitory
avoidance procedure to investigate which components of the
inhibitory avoidance training experience (i.e., memory of the
context or the footstock were influenced by our drug manip-
ulations). Whereas a GR agonist or oxotremorine infused into
the BLA enhanced memory of both the contextual and foot-
shock components of inhibitory avoidance training (Malin et al.,
2007; Roozendaal et al., 2009), the same drugs infused into the
hippocampus selectively enhanced memory of the contextual
information of the task (Malin et al., 2007; Roozendaal et al.,
2009). However, corticosterone administration into the dorsal
striatum did not enhance memory of either the contextual or
aversivelymotivational aspects of the task (Medina et al., 2007). In
view of the evidence that the dorsal striatum is essentially involved
in learning and memory of procedural or implicit forms of train-
ing (Jog et al., 1999; DeCoteau and Kesner, 2000; Packard et al.,
2001; Packard and Wingard, 2004; Reiss et al., 2005; Izquierdo
et al., 2006; Packard, 2009), these findings led to the suggestion
that glucocorticoids might act within the dorsal striatum to selec-
tively enhance memory consolidation of procedural aspects of
inhibitory avoidance training. This view was supported by the
finding that corticosterone infused into the dorsal striatum after
water maze training also selectively enhanced memory of cued
training, without affecting memory of spatial training (Quirarte
et al., 2009). Thus, these findings indicate that although glu-
cocorticoids and cholinergic system act in many different brain
regions to enhance memory consolidation of inhibitory avoid-
ance training, each of the brain regions might contribute in
a unique fashion to enhance the consolidation of memory of
specific components of information acquired during the task.
In summary, the findings presented in this work indicate that
memory consolidation of inhibitory avoidance learning is facili-
tated by the concurrent activity of the striatal cholinergic system
and glucocorticoids. Based on our prior studies, they further sug-
gest that it is the memory of the procedural attributes of this
task that was influenced by these interactions. It would seem
important to determine whether the striatal cholinergic system is
actually involved in the procedural aspects of inhibitory avoid-
ance memory, as in the case of glucocorticoids in this brain
region.
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